Skip to main content

The auto-injector that leads the way in drug development trends

Michael Earl, Director of Pharmaceutical Services at Owen Mumford, discusses how careful planning and a Covid-compliant study design helped Owen Mumford finalize and successfully launch this innovative product.

OCTOBER 2022
Share the article

The Aidaptus platform disposable auto-injector was created to meet the key needs of both patients and pharmaceutical manufacturers.

Key highlights:

  • OM’s Aidaptus brings users a reliable injection process. There are two main steps in the injection, where the needle insertion and medicine delivery are each powered by separate springs.
  • The Aidaptus’ design keeps the needle fully covered before, during, and after use. This can help make injections feel less daunting and may promote better treatment adherence.
  • The Aidaptus’ design is intended to let pharmaceutical manufacturers adjust drug volume and thickness without switching out their chosen delivery device.

Simplifying the injection process

Platform devices are built to support a wide variety of drug delivery needs and work with many formulations throughout clinical trials and a product’s full life. This helps cut down on the amount of testing and regulatory work needed to select a device for each formulation. However, this also means device developers must think about the needs of different patient groups – since the final use case might not be known yet – and make sure any potential risks with use are considered. These factors should address the entire process, from using the device to disposing of it.

Aidaptus 

The Aidaptus disposable auto-injector provides a repeatable, standardized injection process for users. The device uses two steps: the needle is inserted and then the drug is administered, both controlled by separate springs. The needle is automatically triggered when pressed to the injection site, and then the medicine is delivered. This two-step system can help prevent drug loss or “wet injections” before the shot is finished. Users can clearly see and track dose delivery thanks to the bright yellow plunger rod in the viewing window, plus audible clicks start and finish each dose. The window also lets users inspect the drug before injecting and check its clarity and color.

Getting an injection can be stressful or scary, and some people have a fear of needles. The Aidaptus’ design keeps the needle hidden before, during, and after the injection, which helps take away some of that anxiety and supports ongoing treatment. To keep patients safe, the protective shroud locks into place as soon as the injection is complete, so the needle can’t be accessed before it’s dropped into a sharps container.

Built for flexibility

Getting from drug development to clinical trials and regulatory approval now happens faster than it used to, creating pressure on drug delivery devices to adapt — ideally without causing product delays. These devices should allow for changes to the drug formula, development, or lifecycle management, all while sticking to tight schedules.

The Aidaptus’ design gives drug makers the flexibility to change drug volume and viscosity without needing a new delivery device. Its patented, self-adjusting plunger works across a variety of syringe fill sizes with no device modifications or new parts needed. The auto-injector can hold either a 1mL or 2.25mL prefilled syringe, requiring very few part changes and keeping the device compact (162mm x 18mm). It also supports both vented and vacuum filling, so manufacturers have options for their filling partners.

As the drug delivery device field evolves, Aidaptus’ overwrap can be customized to add things like Near Field Communication (NFC) for better connectivity. Thanks to this versatility, drug developers can keep their focus on making life easier for patients and worry less about whether their chosen device is both right for their formulation and easy to use.

Get in touch

* Field is required.